Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1 Gastrointestinal 1 Classical hematology 1

Conditions

Thromboembolism 1 Pancreatic Neoplasms 1

Interventions

Oxaliplatin 288 Capecitabine 218 Fluorouracil 212 Irinotecan 145 Leucovorin 139 Gemcitabine 124 S 1 (combination) 110 apatinib 109 Cisplatin 102 Drug Therapy 98 Bevacizumab 98 Radiotherapy 97 Paclitaxel 97 camrelizumab 89 sintilimab 79 Cetuximab 75 lenvatinib 62 Neoadjuvant Therapy 61 tislelizumab 55 Surgical Procedures, Operative 54 Sorafenib 53 Folfox protocol 53 toripalimab 52 Docetaxel 52 130-nm albumin-bound paclitaxel 47 Laparoscopy 41 HMPL-013 40 XELOX 39 Radiosurgery 36 Albumin-Bound Paclitaxel 36

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Tinzaparin × Gastrointestinal × Clear all

NCT05178628 2022-03-29

imPaCT-PRO

Institute of Molecular Medicine and Biomedical Research

Phase 3 Unknown

Gastrointestinal

Pancreatic Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡